Short communication: Efficiently inhibiting HIV-1 replication by a prototype foamy virus vector expressing novel H1 promoter-driven short hairpin RNAs

AIDS Research and Human Retroviruses

Volumn 31, Issue 2, 2015, Pages 183-188

  Cheng, Qingqing ^a,b   Dong, Lanlan ^a,b   Zhang, Fengfeng ^a   Yuan, Peipei ^a   Li, Zhi ^c   Sun, Yan ^c   Yin, Jun ^a   Peng, Biwen ^a,d   He, Xiaohua ^a,d   Liu, Wanhong ^a,b  

^a WUHAN UNIVERSITY   (China)

^b Hubei Province Key Laboratory of Allergy and Immunology ^*  (China)

^c SHANXI NORMAL UNIVERSITY   (China)

^d HUBEI PROVINCIAL KEY LABORATORY OF DEVELOPMENTALLY ORIGINATED DISEASE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; LACTATE DEHYDROGENASE; MESSENGER RNA; PLASMID VECTOR; RETROVIRUS VECTOR; SHORT HAIRPIN RNA; TRANSACTIVATOR PROTEIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BIOLOGICAL PRODUCT; DRUG CARRIER; SMALL INTERFERING RNA;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DUAL LUCIFERASE REPORTER ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LACTATE DEHYDROGENASE ASSAY; LONG TERMINAL REPEAT; LUCIFERASE ASSAY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RECOMBINANT PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPUMA VIRUS; TRANSIENT TRANSFECTION; VIRAL GENE DELIVERY SYSTEM; VIRUS INHIBITION; VIRUS REPLICATION; WESTERN BLOTTING; CELL LINE; CELL SURVIVAL; DRUG EFFECTS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE THERAPY; GENE VECTOR; GENETICS; METABOLISM; PHYSIOLOGY; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; SPUMAVIRUS; T LYMPHOCYTE; VIROLOGY;

ANTI-HIV AGENTS; BIOLOGICAL PRODUCTS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; DRUG CARRIERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC THERAPY; GENETIC VECTORS; HIV-1; HUMANS; L-LACTATE DEHYDROGENASE; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SPUMAVIRUS; T-LYMPHOCYTES;

EID: 84923220536     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2014.0217     Document Type: Article

References (20)

1. Strayer DS, Akkina R, Bunnell BA, et al.: Current status of gene therapy strategies to treat HIV/AIDS. Mol Ther 2005;11:823-842.
2. Zhou J and Rossi JJ: Current progress in the development of RNAi-based therapeutics for HIV-1. Gene Ther 2011;18:1134-1138.
3. Sidahmed A, Abdalla S, Mahmud S, et al.: Antiviral innate immune response of RNA interference. J Infect Dev Ctries 2014;8:804-810.
4. Hawkins PG, Santoso S, Adams C, et al.: Promoter targeted small RNAs induce long-Term transcriptional gene silencing in human cells. Nucleic Acids Res 2009;37:2984-2995.
5. Olszko ME and Trobridge GD: Foamy virus vectors for HIV gene therapy. Viruses 2013;5:2585-2600.
6. Zhang Y, Liu W, He X, et al.: Foamy virus: An available vector for gene transfer in neural cells and other nondividing cells. J Neurovirol 2010;16:419-426.
7. Deyle DR, Li Y, Olson EM, et al.: Nonintegrating foamy virus vectors. J Virol 2010;84:9341-9349.
8. Horino S, Uchiyama T, So T, et al.: Gene therapy model of X-linked severe combined immunodeficiency using a modified foamy virus vector. PLoS One 2013;8:e71594.
9. Burtner CR, Beard BC, Kennedy DR, et al.: Intravenous injection of a foamy virus vector to correct canine SCIDX1. Blood 2014;123:3578-3584.
10. Liu W, Liu Z, Li W, et al.: A novel human foamy virus mediated gene transfer of GAD67 reduces neuropathic pain following spinal cord injury. Neurosci Lett 2008;432: 13-18.
11. Cave E, Weinberg MS, Cilliers T, et al.: Silencing of HIV-1 subtype C primary isolates by expressed small hairpin RNAs targeted to gag. AIDS Res Hum Retroviruses 2006; 22:401-410.
12. Taylor JA, Vojtech L, Bahner I, et al.: Foamy virus vectors expressing anti-HIV transgenes efficiently block HIV-1 replication. Mol Ther 2008;16:46-51.
13. Kiem HP, Wu RA, Sun G, et al.: Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo. Gene Ther 2010;17:37-49.
14. Singh A, Palanichamy JK, Ramalingam P, et al.: Longterm suppression of HIV-1C virus production in human peripheral blood mononuclear cells by LTR heterochromatization with a short double-stranded RNA. J Antimicrob Chemother 2014;69:404-415.
15. De Arellano ER, Soriano V, and Holguin A: Genetic analysis of regulatory, promoter, and TAR regions of LTR sequences belonging to HIV type 1 non-B subtypes. AIDS Res Hum Retroviruses 2005;21:949-954.
16. Dahiya S, Liu Y, Nonnemacher MR, et al.: CCAAT enhancer binding protein and nuclear factor of activated T cells regulate HIV-1 LTR via a novel conserved downstream site in cells of the monocyte-macrophage lineage. PLoS One 2014;9:e88116.
17. Green VA, Arbuthnot P, and Weinberg MS: Impact of sustained RNAi-mediated suppression of cellular cofactor Tat-SF1 on HIV-1 replication in CD4 + T cells. Virol J 2012;9:272.
18. Trobridge G, Josephson N, Russell DW, et al.: Improved foamy virus vectors with minimal viral sequences. Mol Ther 2002;6:321-328.
19. Weber ND, Merkel OM, Kissel T, et al.: PEGylated poly(ethylene imine) copolymer-delivered siRNA inhibits HIV replication in vitro. J Control Release 2012;157: 55-63.
20. Von Eije KJ, ter Brake O, and Berkhout B: Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference. J Virol 2008;82:2895-2903.